Chevron Corporation (CVX)
- Previous Close
148.82 - Open
152.48 - Bid 152.91 x 800
- Ask 153.07 x 800
- Day's Range
151.71 - 155.93 - 52 Week Range
135.37 - 167.11 - Volume
11,430,070 - Avg. Volume
7,207,137 - Market Cap (intraday)
272.924B - Beta (5Y Monthly) 1.08
- PE Ratio (TTM)
16.84 - EPS (TTM)
9.09 - Earnings Date Jan 31, 2025 - Feb 4, 2025
- Forward Dividend & Yield 6.52 (4.38%)
- Ex-Dividend Date Aug 19, 2024
- 1y Target Est
168.50
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.
www.chevron.comRecent News: CVX
View MoreRelated Videos: CVX
Performance Overview: CVX
Trailing total returns as of 11/1/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CVX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CVX
View MoreValuation Measures
Market Cap
272.92B
Enterprise Value
292.10B
Trailing P/E
16.82
Forward P/E
12.50
PEG Ratio (5yr expected)
3.20
Price/Sales (ttm)
1.45
Price/Book (mrq)
1.75
Enterprise Value/Revenue
1.51
Enterprise Value/EBITDA
7.06
Financial Highlights
Profitability and Income Statement
Profit Margin
9.59%
Return on Assets (ttm)
6.04%
Return on Equity (ttm)
11.76%
Revenue (ttm)
195.15B
Net Income Avi to Common (ttm)
18.72B
Diluted EPS (ttm)
9.09
Balance Sheet and Cash Flow
Total Cash (mrq)
4.01B
Total Debt/Equity (mrq)
14.47%
Levered Free Cash Flow (ttm)
15.96B
Research Analysis: CVX
View MoreCompany Insights: CVX
CVX does not have Company Insights
Research Reports: CVX
View MoreArgus Quick Note: Weekly Stock List for 10/07/2024: Investing in High-Yield Stocks
Value stocks -- a market segment that includes high-yield stocks - is the place to achieve income. The recent yield on the iShares Russell 1000 Value Index ETF was 1.8%, compared to the 0.4% current yield on the iShares Russell 1000 Growth Index ETF. Growth stocks have a history of outperforming value stocks, but value has had its day. Value outperformed growth stocks in 2022. That's a recent rarity, as for more than a decade, the performance record favored growth. Since 2010, the Russell 1000 Growth Index has climbed more than 575%, compared to an advance of almost 200% for the Russell 1000 Value Index. In 10 of the past 13 years, growth stocks have topped value stocks. That hasn't always been the case. In the 2000-2010 decade, including the Great Recession, value stocks were better performers than growth stocks, advancing an admittedly low 8% (but still better than growth, which declined 15% during the decade). Value investors trace their roots to the famous "Security Analysis" textbook, written by Ben Graham, an economics professor at Columbia University. Warren Buffett was one of his students. Why the recent deviation in performance? Several reasons, including changes in the make-up of the economy, growth in intangible assets, and the current level of interest rates. The tide turned back in 2022, at least for a while, as the rollout of COVID-19 vaccines gave a lift to some of the cyclical companies (energy and regional banks) that had lagged in recent years. For our list this week, we have screened our coverage universe for stocks that are BUY-rated by Argus Research analysts, have an Argus Financial Strength Rating of at least Medium, and have a yield of 3.0% or higher. These stocks are also featured in our High-Yield Theme Model Portfolio.
Large Cap US Pick List - October 2024
This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.
Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover
In this edition, playing the long game on commercial turbine engines; making the case for integrated oils despite the headlines; watching where Prudential tilts; and Nike, Novo Nordisk, and Zhejiang Supor.
Large Cap US Pick List - September 2024
This pick list highlights constituents of the Morningstar US Large Cap Index that we believe offer investors the best risk-adjusted return prospects. Stocks of large-cap companies where neither growth nor value characteristics predominate. Stocks in the top 70% of the capitalization of the U.S. equity market are defined as large cap.